Traws Pharma is a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases. The company is advancing investigational oral small molecule antiviral agents, including ratutrelvir for COVID-19 and tivoxavir marboxil for influenza.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.